Wardman A G, Knox A J, Muers M F, Page R L
Leeds Chest Clinic.
Br J Dis Chest. 1988 Jul;82(3):285-9. doi: 10.1016/0007-0971(88)90070-8.
Treatment compliance was assessed by testing multiple urine samples for rifampicin in 113 consecutive patients taking a rifampicin containing regimen for tuberculosis. Nineteen (16.8%) patients had at least one negative urine sample after chromatographic analysis and these patients were more likely to be from social classes IV and V, to be Asian, and to have defaulted from at least one clinic appointment without good reason. A questionnaire was completed by 70 of the patients and four (6%) admitted to having omitted at least one treatment weekly; two of these also had at least one negative urine test. Physicians were only partly successful in identifying non-compliers. The relevance of these findings is discussed.
通过检测113例连续服用含利福平抗结核治疗方案患者的多个尿液样本评估治疗依从性。19例(16.8%)患者经色谱分析后至少有一次尿液样本呈阴性,这些患者更可能来自社会阶层IV和V,为亚洲人,且曾无故缺席至少一次门诊预约。70例患者完成了一份问卷,其中4例(6%)承认每周至少漏服一次治疗药物;其中2例患者的尿液检测也至少有一次呈阴性。医生在识别不依从患者方面仅取得部分成功。文中讨论了这些发现的相关性。